Table 3.
AT2 agonist | Species/model | Dosage | Result | Reference |
---|---|---|---|---|
C21 | L-NAME-induced hypertension | 0.3 mg/kg BW IP | Reduced aortic wall thickness and collagen content; lowered pulse wave velocity | 31 |
C21 | SHR | 1 mg/kg BW PO | Reduced mesenteric artery stiffness; reduced aortic collagen and fibronectin content; lowered oxidative stress | 32 |
Abbreviations: AT2R, angiotensin type 2 receptor; BW, body weight; IP, intraperitoneally; L-NAME, Nω-nitro-L-arginine methyl ester hydrochloride; PO, orally; SHR, spontaneously hypertensive rats.